Projects per year
Personal profile
Biography
Professor Steve Webb MBBS, MPH, PhD, FRACP, FCICM, FAAHMS
Dr Steve Webb is an Intensive Care specialist and a Professor of Critical Care Research. He is a past-Chair of the Australian Clinical Trials Alliance, the ANZICS Clinical Trials Group and of the federal Government’s Clinical Trials Collaborative Forum. In 2014, when the federal Government established the Australian Academy of Health and Medical Sciences, he was one of 14 fellows who were selected to establish the Academy.
He has been an investigator on trials with an accumulated sample size of more than 60,000 patients, is a named investigator on more than $180M of competitive research funding and has published more than 250 manuscripts, including multiple manuscripts in NEJM (11) and JAMA (15), that have been cited more than 75,000 times. He has experience with Bayesian adaptive platform trials and other innovative designs such as cluster cross-over trials. He was the global leader of the REMAP-CAP platform trial that reported the treatment effect of 18 different interventions for patients with severe COVID-19 infection. Results from his trials have been incorporated rapidly into international guidelines and implemented into clinical practice saving many lives.
His vision is that research will be purpose driven for impact, focusing on generating and implementing evidence that will improve patient outcomes and performance of the healthcare sector.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Platform trials
- Intensive care medicine
- Critical Illness
- Critical care
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Antithrombotic therapy to ameliorate clinical complications in community acquired pneumonia (ATTACC-CAP)
McQuilten, Z. (Primary Chief Investigator (PCI)), Tong, S. Y. C. (Chief Investigator (CI)), Webb, S. (Chief Investigator (CI)), Higgins, L. (Chief Investigator (CI)), Ryan, L. (Chief Investigator (CI)), Venkatesh, B. (Chief Investigator (CI)), Roberts, J. A. (Chief Investigator (CI)), Tran, H. (Chief Investigator (CI)), Zarychanski, R. (Chief Investigator (CI)), McFadyen, J. (Chief Investigator (CI)), Aung, A. K. (Chief Investigator (CI)), Lawler, P. (Chief Investigator (CI)), Winearls, J. (Chief Investigator (CI)) & Burrell, A. (Chief Investigator (CI))
1/07/24 → 30/06/28
Project: Research
-
A national critical care research platform to ensure high-quality sepsis care in Australian ICU’s
Udy, A. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)), Saxena, M. K. (Chief Investigator (CI)), Serpa Neto, A. (Chief Investigator (CI)), Higgins, L. (Chief Investigator (CI)), Delaney, A. (Chief Investigator (CI)), Eastwood, G. (Chief Investigator (CI)), Jones, D. (Chief Investigator (CI)), Shekar, K. (Chief Investigator (CI)), Hammond, N. (Chief Investigator (CI)), Thompson, K. J. (Chief Investigator (CI)), Litton, E. (Chief Investigator (CI)), Young, P. J. (Chief Investigator (CI)), Haines, K. (Chief Investigator (CI)), Deane, A. (Chief Investigator (CI)), Bellomo, R. (Associate Investigator (AI)), Cooper, J. (Associate Investigator (AI)), Hodgson, C. (Associate Investigator (AI)), Webb, S. (Associate Investigator (AI)), Cohen, J. (Associate Investigator (AI)), French, C. J. (Associate Investigator (AI)), Peake, S. (Associate Investigator (AI)), Pilcher, D. (Associate Investigator (AI)), Campbell, L. T. (Associate Investigator (AI)) & Finfer, S. (Associate Investigator (AI))
Department of Health and Aged Care (Australia)
1/02/23 → 31/01/28
Project: Research
-
Adaptive platform trial for severe community acquired pneumonia: new interventions for severe CAP and influenza
Webb, S. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)), Nichol, A. (Chief Investigator (CI)), Hills, T. (Chief Investigator (CI)), Higgins, L. (Chief Investigator (CI)), Burrell, A. (Chief Investigator (CI)), McKenzie, A. E. (Chief Investigator (CI)), Cheng, A. (Chief Investigator (CI)), Seppelt, I. (Chief Investigator (CI)) & McArthur, C. (Chief Investigator (CI))
1/06/22 → 31/05/27
Project: Research
-
A coordinated multiplatform randomised trial for hospitalised patients with COVID-19
Webb, S. (Primary Chief Investigator (PCI)), Tong, S. Y. C. (Chief Investigator (CI)), McQuilten, Z. (Chief Investigator (CI)), Davis, J. (Chief Investigator (CI)), Nichol, A. (Chief Investigator (CI)), Totterdel, J. (Chief Investigator (CI)), Higgins, L. (Chief Investigator (CI)), Hammond, N. (Chief Investigator (CI)), Cheng, A. (Chief Investigator (CI)), Roberts, J. A. (Chief Investigator (CI)), Burrell, A. (Chief Investigator (CI)), Denholm, J. T. (Chief Investigator (CI)), Venkatesh, B. (Chief Investigator (CI)), McKenzie, A. E. (Chief Investigator (CI)) & McArthur, C. (Chief Investigator (CI))
1/06/22 → 31/05/27
Project: Research
-
The Staphylococcus aureus Network Adaptive Platform Trial
Tong, S. Y. C. (Primary Chief Investigator (PCI)), Davis, J. (Chief Investigator (CI)), Webb, S. (Chief Investigator (CI)), Cheng, A. (Chief Investigator (CI)), Marsh, J. (Chief Investigator (CI)), Berry, S. M. (Chief Investigator (CI)), Lye, D. C. (Chief Investigator (CI)), Daneman, N. (Chief Investigator (CI)), Bowen, A. C. (Chief Investigator (CI)) & Paterson, D. L. (Chief Investigator (CI))
1/01/22 → 31/12/25
Project: Research
-
Adverse events during and after early mobilisation: A post hoc analysis of the TEAM trial
Broadley, T., Serpa Neto, A., Bailey, M., Bellomo, R., Brickell, K., Buhr, H., Gabbe, B. J., Gould, D. W., Harrold, M., Hurford, S., Iwashyna, T. J., Nichol, A. D., Presneill, J. J., Schaller, S. J., Sivasuthan, J., Tipping, C. J., Webb, S., Young, P. J., Higgins, A. M. & Hodgson, C. L., May 2025, In: Australian Critical Care. 38, 3, 7 p., 101156.Research output: Contribution to journal › Article › Research › peer-review
Open Access4 Citations (Scopus) -
Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia: The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial
Angus, D. C. & The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial, Apr 2025, In: Intensive Care Medicine. 51, 4, p. 665-680 16 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access21 Citations (Scopus) -
Global collaboration between platform trials in surgery and anaesthesia
Glasbey, J., Webb, S. A., Peel, T., Pinkney, T. D. & Myles, P. S., Feb 2025, In: British Journal of Anaesthesia. 134, 2, p. 259-262 4 p.Research output: Contribution to journal › Editorial › Other › peer-review
1 Citation (Scopus) -
Publisher Correction: Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia: The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial (Intensive Care Medicine, (2025), 51, 4, (665-680), 10.1007/s00134-025-07861-w)
The REMAP-CAP Investigators, Jul 2025, In: Intensive Care Medicine. 51, 7, p. 1415 1 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access -
Rinaldo Bellomo and the ‘Dark Arts’ of clinical trials
Webb, S. A. (Leading Author) & Higgins, A. M. (Leading Author), Sept 2025, In: Critical Care and Resuscitation. 27, 3, 2 p., 100146.Research output: Contribution to journal › Editorial › Other › peer-review
Open Access